Medicus Pharma enters USD 22.86 million secured note deal with Streeterville Capital

Medicus Pharma Ltd

Medicus Pharma Ltd

MDCX

0.00

  • Medicus Pharma closed a note purchase agreement with Streeterville Capital for two secured promissory notes totaling USD 22.86 million.
  • Streeterville funded USD 12 million at closing; another USD 10 million was placed in a controlled deposit account at Lakeside Bank.
  • Secured Promissory Note A-1 carries 8.75% interest, an USD 834,225 original issue discount; matures 18 months from issuance.
  • Secured Promissory Note B carries 5% interest; no original issue discount; matures 18 months from issuance.
  • About USD 2.5 million repaid and extinguished a YA II PN debenture; proceeds earmarked for clinical development, business development, general corporate uses.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medicus Pharma Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001062993-26-002900), on May 27, 2026, and is solely responsible for the information contained therein.